TipRanks
Go Ultimate55% OFF

Rainbow Rare Earths (RBWRF) AI Stock Analysis

RBWRF

Rainbow Rare Earths

(Other OTC:RBWRF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Attractive Project EconomicsThe Uberaba assessment indicates potentially strong long-term project economics, with high expected returns, substantial annual EBITDA and a multi-decade operating life. If execution matches the study, these characteristics could support durable cash generation and strengthen Rainbow’s position in Western rare earth supply.
Negative Factors
Pre-Revenue LossesRainbow remains pre-revenue and continues to report material losses, so its projects have not yet demonstrated operating cash generation. The 2026 deterioration in net loss underscores the long path to profitability and leaves future financial performance dependent on successful development and production.

Rainbow Rare Earths (RBWRF) vs. SPDR S&P 500 ETF (SPY)

-25%0%25%50%75%100%125%150%175%RBWRF+108.70%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
$136.96M
Dividend Yield
―
Average Volume (3M)
4,385
Price to Earnings (P/E)
-23.1
Beta (1Y)
-1.60
Revenue Growth
―
EPS Growth
-132.65%
Country
US
Employees
40
Sector
Basic Materials
Sector Strength
61
Industry
Other Precious Metals

Rainbow Rare Earths Business Overview & Revenue Model

Company Description

Rainbow Rare Earths Limited specializes in the exploration and extraction of rare earth minerals, particularly focusing on deposits rich in neodymium and praseodymium. A key asset for the company is its 90% stake in the Gakara project, encompassing a...

Rainbow Rare Earths Earnings Call Summary

Earnings Call Date:Mar 30, 2026(Q2-2026)|% Change Since:-11.80%|Next Earnings Date:Mar 23, 2027
Earnings Call SentimentPositive

The call presents multiple strong positives: attractive project economics (high EBITDA, high IRR, low CapEx), successful pilot results and process optimizations, solid strategic partnerships (DFC, Mosaic, TechMet, Traxys), recent capital raise and clear ESG benefits from recovering rare earths from phosphogypsum. Key negatives are a ~1-year schedule delay caused by a failed external technology partner and the subsequent pivot, dependence on project financing and commodity price sensitivity. On balance the highlights are substantial and materially outweigh the lowlights, with management portraying a de-risked, lower-cost pathway to production backed by pilot data and strategic partners.

Positive Updates

Strong Project Economics — Phalaborwa
Phalaborwa projected to generate ~$181M EBITDA per annum (based on Dec 2024 spot NdPr at $110/kg) with ~16-year life, low CapEx of ~US$320M, and very high margins; management notes NdPr traded at ~$140/kg earlier in 2026 (~27% above the $110/kg used in the model), implying upside to EBITDA.

Negative Updates

Timeline Delay from Expected Milestones
Pivot away from an intended continuous ion chromatography route (technology partner in Florida failed to deliver) to solvent extraction added ~1 year to the timeline; Phalaborwa production target slipped to late 2028/early 2029 and Uberaba to 2030.

Company Guidance

Management guidance summarized: management expects to complete the Phalaborwa DFS by end‑2026, target FID end Q3 2027, start construction in 2028 and first production late‑2028/early‑2029 (Uberaba targeted for 2030); published project metrics use a 10% discount (DFC agreed 9.5%), with Phalaborwa CapEx ~USD 320M, 16‑year life and ~USD 181M EBITDA pa (NdPr benchmark $110/kg; spot hit $140/kg earlier), and Uberaba CapEx ~USD 280M, >30‑year life, ~USD 217M EBITDA pa, NPV ~USD 1bn and IRR >45% (EBITDA margins >70%); resource grades ~4,400 ppm TREO (Phalaborwa) and ~5,100 ppm TREO (Uberaba), stacked gypsum volumes ~35Mt ×2 (Phalaborwa) and >85Mt (Brazil) with ~4.5Mtpa gypsum production in Brazil; pilot plant is continuous (24/7) producing ~1 kg/day mixed rare earth hydroxide >75% TREO, pilot PLS flow reduced from ~340 to 40–50 m3/h after CIX and to ~3–4 m3/h into SX, leach stages cut from 3→2 and resin contact time from 32h→8h, conservative resin replacement assumed every 5 years; financing update: raised USD 14.6M at 20p (90% US), current cash burn ~USD 400k/month (~35 months runway), plan project finance ~2/3 debt : 1/3 equity, Rainbow to issue 38M shares to buy remaining 15% Phalaborwa and holds 49% of Uberaba (Mosaic 51%); payability assumptions: MREC ~65–70% (high‑grade ~70%), separated NdPr ~100% payability (≈75% of basket under Chinese pricing).

Rainbow Rare Earths Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

RBWRF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
GB:ALLGB:ALL50NeutralGBP 131.45M-33.68-14.73%――-2.08%
GB:POWGB:POW46NeutralGBP 12.75M-2.77-14.52%―――
GB:CRTMGB:CRTM45NeutralGBP 91.59M-473.68-6.57%―――
GB:PREGB:PRE40UnderperformGBP 173.22M-0.06-13.98%―――

* Basic Materials Sector Average

Performance Comparison

0%200%400%600%800%RBWRFGB:ALLGB:POWGB:PREGB:CRTMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
RBWRF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
RBWRFRainbow Rare Earths0.480.25110.53%
GB:ALLAtlantic Lithium Ltd.16.407.5084.27%
GB:POWPower Metal Resources Plc10.10-3.15-23.77%
GB:PREPensana Rare Earths PLC49.00-63.00-56.25%
GB:CRTMCritical Metals Plc90.0080.00800.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.